Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Breast cancer research: the past and the future

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs

I Holen, H Neville-Webbe and RE Coleman

Breast Cancer Research 2006, 8(Suppl 2):S12 doi:10.1186/bcr1555

Accesses  

  • Last 30 days: 10 accesses
  • Last 365 days: 153 accesses
  • All time: 521 accesses